Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) — Salt Lake City, Utah

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) is a clinical research site located in Salt Lake City, Utah, United States 84106.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) has participated in 6 clinical trials.

Therapeutic areas: Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salt Lake City

Browse all research sites in Utah · View every site in Salt Lake City

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Utah Cancer Specialists Dept.of Utah Cancer Spec. (3)?

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) conducted?

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) has 6 clinical trials on record. Their work covers Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Breast Cancer.

Is Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) accredited by Crixeo Clinical Trials?

Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Utah Cancer Specialists Dept.of Utah Cancer Spec. (3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.